Proteomics Intl Labs Ltd has released a press release.
Proteomics International seeks FDA approval for PromarkerD
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- December 2020 Quarterly Activities Report and Appendix 4C
- AGM Investor Presentation
- Middle East is next market for PromarkerD immunoassay test
- PromarkerD clinical assay performance results published
- Proteomics receives $1.1 million in R&D tax incentive
Later from Proteomics International Laboratories
- Response to Price Query
- ISO 13485 certification received - Manufacturing Update
- March 2021 Quarterly Activities Report and Appendix 4C
- Major economic health benefit demonstrated for PromarkerD
- Proteomics secures major analytical services contract
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories